A recent publication revealed that an anti-mouse CD83 monoclonal antibody (DCR-5) targets CD83 and causes the depletion of pre-existing DCs while increasing levels of Treg and regulatory DCs in a mouse model of RA [177]. Here, CD83 is linked to rheumatoid arthritis.